165 related articles for article (PubMed ID: 35477705)
1. Use of Lithium in Hyperthyroidism Secondary to Graves' Disease: A Case Report.
Sharma PP
Am J Case Rep; 2022 Apr; 23():e935789. PubMed ID: 35477705
[TBL] [Abstract][Full Text] [Related]
2. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy.
Yoshihara A; Iwaku K; Noh JY; Watanabe N; Kunii Y; Ohye H; Suzuki M; Matsumoto M; Suzuki N; Tadokoro R; Sekiyama C; Hiruma M; Sugino K; Ito K
Thyroid; 2019 Jan; 29(1):128-134. PubMed ID: 30426886
[TBL] [Abstract][Full Text] [Related]
4. Graves Disease Following Subacute Thyroiditis in a Chinese Man.
Al-Bacha S; Lahiri SW
AACE Clin Case Rep; 2022; 8(2):73-77. PubMed ID: 35415228
[TBL] [Abstract][Full Text] [Related]
5. The effect of short-term treatment with lithium carbonate on the outcome of radioiodine therapy in patients with long-lasting Graves' hyperthyroidism.
Sekulić V; Rajić M; Vlajković M; Ilić S; Stević M; Kojić M
Ann Nucl Med; 2017 Dec; 31(10):744-751. PubMed ID: 28895066
[TBL] [Abstract][Full Text] [Related]
6. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Randomized Controlled Trials Comparing the Efficacy of Radioactive Iodine Monotherapy versus Radioactive Iodine Therapy and Adjunctive Lithium for the Treatment of Hyperthyroidism.
Ahmed FW; Kirresh OZ; Majeed MS; Iftikhar M; Sajid MS
Endocr Res; 2021 Nov; 46(4):160-169. PubMed ID: 34028325
[No Abstract] [Full Text] [Related]
8. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
Suzuki N; Yoshihara A; Yoshimura Noh J; Kinoshita K; Ohnishi J; Saito M; Sugino K; Ito K
Endocr J; 2020 Oct; 67(10):1019-1022. PubMed ID: 32522908
[TBL] [Abstract][Full Text] [Related]
9. The tale of radioiodine and Graves' orbitopathy.
Ponto KA; Zang S; Kahaly GJ
Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
[TBL] [Abstract][Full Text] [Related]
10. Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
Kahaly GJ
J Clin Endocrinol Metab; 2020 Dec; 105(12):3704-20. PubMed ID: 32929476
[TBL] [Abstract][Full Text] [Related]
11. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
[TBL] [Abstract][Full Text] [Related]
12. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
13. A 30-Year-Old Woman with a History of Autoimmune Hyperthyroidism Presenting with Fever and Oral Ulcers, Diagnosed with Discoid Lupus Erythematosus.
Chen J; Gao Y; Chai Y; Gao H
Am J Case Rep; 2023 Apr; 24():e938988. PubMed ID: 37038339
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of Graves disease.
Streetman DD; Khanderia U
Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
[TBL] [Abstract][Full Text] [Related]
15. Is low radioiodine uptake a contraindication to radioiodine therapy in patients with benign thyroid disease?
Płazińska MT; Czarnywojtek A; Sawicka-Gutaj N; Woliński K; Krela-Kaźmierczak I; Zgorzalewicz-Stachowiak M; Miechowicz I; Gut P; Florek E; Skonieczna-Żydecka K; Ruchała M; Królicki L
Adv Clin Exp Med; 2021 Apr; 30(4):369-378. PubMed ID: 33913262
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factor analysis in 325 patients with Graves' disease treated with radioiodine therapy.
Yang D; Xue J; Ma W; Liu F; Fan Y; Rong J; Yang A; Yu Y
Nucl Med Commun; 2018 Jan; 39(1):16-21. PubMed ID: 29040161
[TBL] [Abstract][Full Text] [Related]
17. Update on Pediatric Hyperthyroidism.
Vaidyanathan P
Adv Pediatr; 2022 Aug; 69(1):219-229. PubMed ID: 35985711
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study.
Chouhan A; Abhyankar A; Basu S
Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804
[TBL] [Abstract][Full Text] [Related]
20. Influence of high tissue-absorbed dose on anti-thyroid antibodies in radioiodine therapy of Graves' disease patients.
Listewnik MH; Piwowarska-Bilska H; Jasiakiewicz K; Birkenfeld B
Adv Clin Exp Med; 2021 Sep; 30(9):913-921. PubMed ID: 34418335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
